org 31710 has been researched along with medroxyprogesterone acetate in 3 studies
Studies (org 31710) | Trials (org 31710) | Recent Studies (post-2010) (org 31710) | Studies (medroxyprogesterone acetate) | Trials (medroxyprogesterone acetate) | Recent Studies (post-2010) (medroxyprogesterone acetate) |
---|---|---|---|---|---|
38 | 3 | 6 | 5,123 | 1,115 | 1,099 |
Protein | Taxonomy | org 31710 (IC50) | medroxyprogesterone acetate (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.924 | |
Glucocorticoid receptor | Homo sapiens (human) | 0.013 | |
Progesterone receptor | Homo sapiens (human) | 2.5081 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.019 | |
Mineralocorticoid receptor | Homo sapiens (human) | 1.197 | |
Androgen receptor | Homo sapiens (human) | 0.0061 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.279 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.019 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.019 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.019 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 1.197 | |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 1.4059 | |
Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 4.0405 | |
Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 1.8 | |
Estrogen receptor beta | Homo sapiens (human) | 0.924 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Groen, MB; Mais, DE; Marschke, KB; Pedram, B; van Oeveren, A; Verbost, PM; Zhi, L | 1 |
Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 1 |
Basar, M; Bozkurt, I; Buchwalder, L; Guzel, E; Kayisli, U; Lockwood, CJ; Ocak, N; Schatz, F | 1 |
3 other study(ies) available for org 31710 and medroxyprogesterone acetate
Article | Year |
---|---|
A tissue-selective nonsteroidal progesterone receptor modulator: 7,9-difluoro-5-(3-methylcyclohex-2-enyl)-2,2,4-trimethyl-1,2-dihydrochromeno[3,4-f]quinoline.
Topics: Animals; Benzopyrans; Female; Haplorhini; Humans; Molecular Structure; Ovulation; Quinolines; Rats; Receptors, Progesterone; Structure-Activity Relationship | 2008 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
Effects of tibolone and its metabolites on prolactin and insulin-like growth factor binding protein-1 expression in human endometrial stromal cells.
Topics: Blotting, Western; Contraceptive Agents, Female; Dexamethasone; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrenes; Estrogen Receptor Modulators; Estrogens; Female; Furans; Glucocorticoids; Hormone Antagonists; Humans; Insulin-Like Growth Factor Binding Protein 1; Medroxyprogesterone Acetate; Mifepristone; Norpregnanes; Norpregnenes; Prolactin; Real-Time Polymerase Chain Reaction; RNA, Messenger; Stromal Cells | 2015 |